Encouraging to see a ticker like NUTX, which has a float in the same ballpark as ours, jump from the mid-$4s to over $10 today on no specific news. They're more of a healthcare technology company than biotech, but it just goes to show that with the right news catalyst even a ticker with a high float like ours still has the potential to really rocket upward in SP. With all of our potential indications, $40-$50 or even higher isn't outside of the realm of possibility.